Patents Assigned to National Health Rsearch Institutes
  • Patent number: 9255072
    Abstract: A compound of formula (I): wherein A, B, D, X, Y, R1, R2, R3, m, p, and q are defined herein. Also disclosed is a method for inhibiting FMS-like tyrosine kinase 3, aurora kinase, or vascular endothelial growth factor receptor.
    Type: Grant
    Filed: March 1, 2012
    Date of Patent: February 9, 2016
    Assignee: National Health Rsearch Institutes
    Inventors: Weir-Torn Jiaang, Tsu-An Hsu, Wen-Hsing Lin, Yu-Sheng Chao